Onconetix Inc. (NASDAQ: ONCO)
$0.15
-0.0004 ( -0.27% ) 729.7K
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
Market Data
Open
$0.15
Previous close
$0.15
Volume
729.7K
Market cap
$3.24M
Day range
$0.14 - $0.15
52 week range
$0.10 - $0.54
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Apr 08, 2024 |
nt | Quarterly Reports | 1 | Apr 01, 2024 |
8-k/a | 8K-related | 16 | Mar 13, 2024 |
8-k/a | 8K-related | 17 | Feb 27, 2024 |
4 | Insider transactions | 1 | Feb 21, 2024 |
3 | Insider transactions | 1 | Feb 16, 2024 |
3 | Insider transactions | 1 | Feb 16, 2024 |
pre | Proxies and info statements | 20 | Feb 14, 2024 |
8-k | 8K-related | 15 | Feb 13, 2024 |
8-k | 8K-related | 16 | Feb 12, 2024 |